Wellness777int.com    Mannatech Independent Associates   Real Food Technology - Cutting Edge Science

Peter Dyck

Mannatech Patents

Glyconutrients 101: The Patents

Posted: 25 Jan 2014 01:50 PM PST

So far, we've shared what glyconutrients are all about along with the revolutionary science behind it. The final piece of this discussion will focus on something that truly makes us stand head and shoulders above the rest.

Our patents.

SO WHAT'S A PATENT ANYWAY? (And why does it matter?)

A patent is a legal form of protection granted to an inventor of a useful product or process (intellectual property), allowing the individual (or company) to retain sole ownership of the thing or the idea, so that others cannot make, use, sell or distribute it without permission. In all countries, patents are valid for a limited number of years (generally about 20 from the filing date in the U.S.), providing the inventor with a reasonable amount of time to share the intellectual property publicly and sell and distribute it exclusively.

Getting a patent is not easy. In fact, the process consists of a rigorous maze of hurdles and qualifications that must be successfully navigated and cleared. After patent applications have been reviewed, thorough examinations have been made and the invention has been exhaustively vetted, then a patent may or may not be granted. If it is, the inventor's idea, or intellectual property, will be protected under a specific set of guidelines and rules. If a patent is infringed upon, the owner may sue the unauthorized user/seller in federal court.

So once a patent is granted, it's serious business and the product or idea is one of great efficacy, value and integrity.

What does this have to do with Mannatech?

Everything.

Patents? Yes, We Have More Than 90 ( 100 patents plus now).

Q: Why is it important to have patents?
A: Patents ensure unique technologies are protected from becoming commodities. There are few nutritional supplement developers that can match Mannatech's 100-plus patents issued in global markets. This exceptional accomplishment establishes Mannatech as a leading global developer of unique, high-value, quality health and wellness products.
Q: Some critics do not believe in glyconutrients. What is Mannatech's stance on *glyconutrition?
A: Mannatech harnessed the benefits of nutritional glycobiology for its products before and better than anyone else.

Transforming Glycoscience by NAS pdf.

Consider Dr. John Rollins*, a top-notch medical biologist. For 15 years, he was a Biotech Patent Examiner at the U.S. Office of Trademarks and Patents in Washington, D.C. He also worked at the Patent Office when the technology behind Ambrotose complex was being reviewed.

Dr. Rollins often shares the story of his first encounter with Ambrotose technology in the 1980s. He was examining a series of patent applications from an inventor, Dr. Bill McAnalley, who claimed he had been able to isolate a particular compound from aloe and that this compound was a saccharide, or complex sugar, that supported the immune system and could affect cell-to-cell communication. Dr. Rollins says he was "skeptical" when he first heard about it because, at that time, in the area of glycobiology technologies, sugars didn't have the reputation for impacting the immune system and cell-to-cell communication.

However, as Dr. Rollins began to examine the technology a little more, he says, "...it was a goose-pimple-raising experience for me."

He continues, "We could see that this discovery really was going against the grain of what glycobiologists were thinking. This theory of supporting the immune system, of supporting cell-to-cell communication, was 180 degrees away from the thinking of the traditional carbohydrate chemist...now, of course, we understand why a new scientific theory, particularly one as bold and game-changing as this is, received such scrutiny".

Two words: Bold. Game-changing.

These two words in the previous quote define why Mannatech's^™ proprietary science is just that — unique, one-of-kind...unshakable.

The fact remains: Patents are not easily granted, as evidenced in the highly critical review process. This is further proof that Mannatech has powerful, innovative technology to offer through our real-food-based products.

That's not all! We are committed to meeting customer, regulatory and industry standards by manufacturing products of the highest quality and value. We adhere to industry-wide current Good Manufacturing Practices established by various U.S. and international regulatory agencies, so you can be assured that our products are safe, beneficial and precisely labeled.

Patents Make Perfect!

*Dr.John Rollins is an Independent Associate with Mannatech.

Under Construction

News Release (this page on wellness777int.com is not formatted yet) MANNATECH ANTIOXIDANT PRODUCT RECEIVES TWO NEW PATENTS Ambrotose AO® capsules granted Decision to Grant for Europe and patent in Indonesia COPPELL, Texas--(BUSINESS WIRE)--Feb. 26, 2014-- Mannatech, Incorporated (NASDAQ: MTEX), the founder of the M5MSM (Mission 5 MillionSM) social entrepreneurial movement, the pioneer of nutritional glycobiology and the leading innovator of naturally-sourced supplements based on Real Food Technology®solutions, announces the issuance of two new patents pertaining to its Ambrotose AO formulations, increasing the total patents held by the company to more than 90. “While the vast majority of antioxidant supplements rely on high-dose synthetic ingredients,” said Dr. Sinnott, CEO and Chief Science Officer at Mannatech, “we knew back in 2003 when we launched Ambrotose AO that a better approach would be to formulate a synergistic blend of fat- and water-soluble food-sourced antioxidant nutrients that resemble the nutrients found in a diet rich in fresh fruits and vegetables. Proof of the benefit of Ambrotose AO supplementation, as measured by increased serum oxygen radical antioxidant capacity (ORAC), has been confirmed in three human clinical trials.1,2,3 The product’s safety has been confirmed during these studies and by 11 years of data collected by our outstanding Safety Monitoring Program.”* Mannatech received the Decision to Grant from the European Patent Office and was issued the Letters Patent for Indonesia pertaining to its Ambrotose AO formulation. More than 25 patents have been issued worldwide to Mannatech for the technology pertaining to this formula. Overall, more than 90 patents have been issued worldwide to Mannatech for the technology pertaining to its Ambrotose, Ambrotose AO, GI-ProBalance®, and PhytoMatrix® product formulations and in the field of biomarker assays. “Mannatech had the foresight to begin developing its patent portfolio in the mid-1990s,” continued Dr. Sinnott. “These two new patents are a direct result of our systematic research and intellectual property development which has continued without pause since the company began.” Individuals interested in Mannatech’s products, or exploring its social entrepreneurial efforts to help fight global malnutrition, can learn more at Mannatech.com. Those interested in obtaining technical information and reading published product studies may visit MannatechScience.org. About Mannatech Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe, including the United States, Canada, South Africa,Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, theRepublic of Korea, Mexico, Namibia, Hong Kong and Ukraine. For more information, visit Mannatech.com. Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commissionand cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release. Reference List 1. Boyd S, Gary K, Koepke CM, et al. An open-label pilot study of the antioxidant effect in healthy people of Ambrotose AO. GlycoScience & Nutrition 2003; 4(6): 1-6. 2. Myers SP, Stevenson L, Cheras PA, et al. A forced titration study of the antioxidant and immunomodulatory effects of Ambrotose AO supplement. BMC Comp Alt Med 2010; 10(16): 1-16. 3. Bloomer RJ, Canale RE, Blankenship MM, et al. Effect of Ambrotose AO on resting and exercise-induced antioxidant capacity and oxidative stress in healthy adults. Nutr J 2010; 9(49): 1-17. These studies were funded by Mannatech. *These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. http://cts.businesswire.com/ct/CT?id=bwnews&sty=20140226006668r1&sid=acqr7&distro=nx Source: Mannatech, Incorporated Mannatech, Incorporated Brett Duncan, 972-471-7367

Read more... Ambrotose^® powders and AmbrotoseAO^® technologies.

More... "The Only Intelligent Choice", by Dr.Steve Nugent

For information contact us at:

1-403-443-2206

[email protected]

Site Map | Back to Ambrotose